# Atux Iskay Group LLC

Canonical: https://abierto.us/vendors/atux-iskay-group-llc-c7jpq5f3uuh7

- UEI: C7JPQ5F3UUH7
- CAGE: 88C46
- Location: Plainsboro, NJ
- Awards in window: 2 (6 transactions), $355,000 obligated, February 12, 2024 to February 11, 2025

## Awarding agencies

- National Institutes of Health: 2 awards, $355,000

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $355,000

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- 75N91024C00009 (definitive contract): $355,000, NIH NCI. SBIR Concept Award - Therapeutics - Sulfonyl-Urea and Sulfonamide PP2A Activators as Mycn Amplified Neuroblastoma (Nbl) Therapeutics. https://www.usaspending.gov/award/CONT_AWD_75N91024C00009_7529_-NONE-_-NONE-/
- 75N91023C00038 (definitive contract): $0, NIH NCI. SBIR Phase I Topic #446 - Development of Senotherapeutic Agents for Cancer Treatment. https://www.usaspending.gov/award/CONT_AWD_75N91023C00038_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/atux-iskay-group-llc-c7jpq5f3uuh7.